Search
for
Sort by
Research 30 of 345
- Maculopapular Drug Eruption Caused by Finasteride: A Case Report
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Efectos adversos dermatológicos con uso de litio
- How does covid-19 affect the skin?
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- COVID-19感染症でみられる皮膚病変
- Dermatological manifestations of Coronavirus Disease 2019 (COVID-19)
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Manifestasi Klinis COVID-19 Pada Kulit
- Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
- Dermatological Manifestations of COVID-19 Patients
- Cutaneous signs in COVID ‐19 patients: A review
- Maculopapular rash upon antibiotic therapy in a patient with rheumatoid arthritis
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Dermatological Manifestations of COVID-19: A Comprehensive Review
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Skin manifestations associated with COVID-19
- Skin amidst COVID ‐19 pandemic
- Unusual Diffuse Hair Loss
- Phenobarbital
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
- Severe and Fatal Phenobarbitone Eruptions